Who is sponsoring NCT00361452?

NCT00361452 is sponsored by Rambam Health Care Campus.

What condition does NCT00361452 study?

NCT00361452 studies Rsv Bronchiolitis.

What drugs are being tested in NCT00361452?

Interventions: nebulized epinephrine and nebulized albuterol.

What is the status of NCT00361452?

NCT00361452 is currently TERMINATED.

Last reviewed 2006-08-06 · How we verify

Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study

NCT00361452 Phase 4 TERMINATED

Bronchiolitis is a common disease of infancy and a main reason for infants' hospital admissions in the first 2 years of life. The main cause of bronchiolitis is RSV (respiratory syncytial virus). Though, Treatment is mainly supportive, the treatment benefit of nebulized epinephrine or albuterol has been largely debated for the past years. Most of the clinical studies used clinical parameters to detect and compare the effectiveness of such medical interventions. In this study we will use non invasive computerized method of wheeze and crackles quantification to compare the effectiveness of nebulized epinephrine vs albuterol in RSV Bronchiolitis.

Details

Lead sponsor	Rambam Health Care Campus
Phase	Phase 4
Status	TERMINATED
Enrolment	30
Start date	2000-12
Completion	2001-05

Conditions

Rsv Bronchiolitis

Interventions

nebulized epinephrine and nebulized albuterol

Primary outcomes

respiratory clinical score
computerized quantification of wheezing and crackles

Countries

Israel